Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Upadacitinib Results in Endoscopic Remission in Patients With Inflammatory Bowel Disease and Prior Tofacitinib Failure.
Journal: Journal of clinical gastroenterology
Published: October 31, 2024
Mycophenolate Mofetil Appears Effective for the Treatment of Patients With Refractory Crohn's Disease.
Journal: Crohn's & colitis 360
Published: August 01, 2024
Tofacitinib Appears Well Tolerated and Effective for the Treatment of Patients with Refractory Crohn's Disease.
Journal: Digestive diseases and sciences
Published: June 14, 2021
Safety and Efficacy of Tofacitinib in Combination With Biologic Therapy for Refractory Crohn's Disease.
Journal: Inflammatory bowel diseases
Published: March 12, 2021
Health Maintenance in Patients with Ulcerative Colitis.
Journal: Gastroenterology clinics of North America
Published: October 30, 2020
Obesity and inflammatory bowel disease: diagnostic and therapeutic implications.
Journal: Current opinion in gastroenterology
Published: January 23, 2018
Interaction of obesity and inflammatory bowel disease.
Journal: World journal of gastroenterology
Published: March 28, 2016
Fulminant hepatitis B reactivation leading to liver transplantation in a patient with chronic hepatitis C treated with simeprevir and sofosbuvir: a case report.
Journal: Journal of medical case reports
Published: December 16, 2014
Increased body mass index is associated with earlier time to loss of response to infliximab in patients with inflammatory bowel disease.
Journal: Inflammatory bowel diseases
Published: July 19, 2013
Co-morbid diabetes in patients with Crohn's disease predicts a greater need for surgical intervention.
Journal: Alimentary pharmacology & therapeutics
Published: November 15, 2011
Showing 1-10 of 10
Last Updated: 09/26/2026